Last updated on August 2019

Open Label Safety Study in Acute Treatment of Migraine

Brief description of study

The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).

Clinical Study Identifier: NCT03266588

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.